These include hypertension, diabetes, smoking, obesity, and a history of dyslipidemia
To find the proportion of ESI enrollees with a prescription for GLP-1 drugs, outpatient pharmaceutical claims from 2012 to 2022 in the Merative MarketScan Commercial Database were used
Others lose less or very little
Food tolerance improves dramatically after week 12 for most patients
Conclusions GSH is a key thiol antioxidant in the human body which, among its many functions, serves as a major mitochondrial protector, and through this function is linked to many chronic illnesses which make up the bulk of the healthcare burden in Western societies today
Others lose 8 to 10 percent despite following the program closely